Projects

Mgr. Andrea Mičurová, PhD.

International

Finished
  • Bench to bedside transition for pharmacological regulation of NRF2 in noncommunicable diseases
    Program: COST
    Duration: 19. 10. 2021 – 18. 10. 2025

National

Current
  • Model of Western diet-induced metabolic dysfunction-associated fatty liver disease (MAFLD) in borderline hypertensive rats: effect of monomethyl fumarate
    Program: VEGA
    Duration: 1. 1. 2025 – 31. 12. 2028
  • The Role of Thyroid Hormones and the NRF2–PPARα Signaling Axis in the Regulation of Lipid Metabolism in a Rat Model of Cardiometabolic Comorbidity
    Program: Other projects
    Duration: 1. 1. 2026 – 31. 12. 2027
  • Identification of stress-induced alterations in expression of NRF2 target genes in rat models of prehypertension: the effect of comorbid hypertriglyceridemia and dimethyl fumarate treatment
    Program: SRDA
    Duration: 1. 7. 2023 – 30. 6. 2027
  • The effect of dimethyl fumarate on nuclear factor erythroid 2-related factor 2 activation and redox balance in chronic stress-exposed female rats with mild hypertension and comorbid hypertriglyceridemia
    Program:
    Duration: 1. 9. 2024 – 31. 8. 2026
Finished
  • New perspectives in the treatment of cardiovascular complications associated with COVID-19
    Program: SRDA
    Duration: 16. 9. 2020 – 31. 12. 2021
Employees